Results 231 to 240 of about 1,026,560 (278)

Engineering tandem VHHs to target different epitopes to enhance antibody‐dependent cell‐mediated cytotoxicity

open access: yesFEBS Open Bio, EarlyView.
Tandem VHH targeting distinct EGFR epitopes were engineered into a monovalent bispecific antibody (7D12‐EGA1‐Fc) with more potent ADCC without increasing affinity to EGFR. Structural modeling of 7D12‐EGA1‐Fc showed cross‐linking of separate EGFR domains to enhance CD16a engagement on NK cells.
Yuqiang Xu   +5 more
wiley   +1 more source

FGFR Like1 drives esophageal cancer progression via EMT, PI3K/Akt, and notch signalling: insights from clinical data and next‐generation sequencing analysis

open access: yesFEBS Open Bio, EarlyView.
Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava   +3 more
wiley   +1 more source

Dysbiosis-Mediated Regulation of Stem Cells the First Hit for Cancer Generation. [PDF]

open access: yesInt J Mol Sci
Gargiulo-Isacco C   +7 more
europepmc   +1 more source

From Inflammation to Malignancy: The Link Between Endometriosis and Gynecological Cancers. [PDF]

open access: yesInt J Mol Sci
Kłodnicka K   +9 more
europepmc   +1 more source

Signaling pathways and targeted interventions for precancers. [PDF]

open access: yesSignal Transduct Target Ther
Yang J   +7 more
europepmc   +1 more source

Retinocytoma: Clinical and Genetic Characteristics in 16 Pediatric and Adult Cases. [PDF]

open access: yesOcul Oncol Pathol
Widehen C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy